Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132291) titled 'Research on the Prediction Model of Remimazolam Anesthesia Induction Dose Based on Multi-modal Fusion Data-Driven Machine Learning Algorithms' on Sept. 11.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The General Hospital of the Central Theater Command
Condition:
None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-30
Target Sample Size: The observation group of remimazolam anesthesia induction dose:400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341993
Disclaimer: Curated by HT Synd...